1st Quarter - Report
COVINGTON & BURLING LLP for CELGENE CORPORATION
Client
Income
$70,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Expressing support for changes to the CREATES Act (S. 3056), Fair Access for Safe and Timely (FAST) Generics Act (H.R. 2051), Lower Drug Costs through Competition Act (H.R. 749) and Senate counterpart (S. 297, Increasing Competition in Pharmaceuticals Act), and Affordable and Safe Prescription Drug Importation Act (S. 469).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTA CARVER | — |
| CHRISTINA KUHN New | — |
| GABRIEL NEVILLE | — |
| WILLIAM WICHTERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.